Alembic debuts generic FaslodexFulvestrant injection is an estrogen receptor antagonist used to treat certain types of breast cancer. Nexus obtains FDA OK for sodium chloride injectionNexus Pharmaceuticals’ product is expected to launch in October and will be available in cartons of 25 vials. Lupin receives FDA OK for generic Esbriet Generic Esbriet is an anti-fibrotic used to treat idiopathic pulmonary fibrosis. Alembic debuts generic Intuniv Guanfacine Extended-Release tablets are indicated for the treatment of ADHD as monotherapy and as adjunctive therapy. Mallinckrodt files for second bankruptcy Mallinckrodt said it intends to pay vendors and suppliers in the ordinary course, including for any pre-petition amounts owed at the time of filing. Sandoz obtains FDA nod for first Tysabri biosimilar Tyruko is the first biosimilar to Tysabri injection for the treatment of adults with relapsing forms of multiple sclerosis. ANI obtains FDA OK for generic Divigel Generic Divigel is indicated for the treatment of moderate to severe hot flashes due to menopause. Camber launches generic Zetia Ezetimibe tablets are an inhibitor of intestinal cholesterol (and related phytosterol) absorption indicated as an adjunct to diet. Mallinckrodt to file for Chapter 11 bankruptcy again Mallinckrodt expects to complete the contemplated prepackaged Chapter 11 process in the fourth quarter of 2023. CVS Health launches Cordavis As its first product, Cordavis has contracted with Sandoz to commercialize and bring to market Hyrimoz, a biosimilar for Humira. First Previous 46 47 48 49 50 Next Last
